Cellectar Biosciences, Inc. (CLRB) Insider Ownership

Data spanning the past 90 days through February 15, 2026 reveals that Cellectar Biosciences's three principal insider shareholders consist of Chief Operating Officer Jarrod Longcor (12.77K shares), Chief Executive Officer James V Caruso (11.64K shares), Chief Financial Officer Chad J Kolean (6.42K shares).

• Cellectar Biosciences, Inc. (CLRB) exhibits a conventional ownership structure with institutions commanding 15.30% of outstanding shares, insider ownership remaining at 1.61%, and public/other investors holding 83.09%.
• As of February 15, 2026, insider ownership at Cellectar Biosciences represents 1.61% of the company's total outstanding shares, comprising approximately 32.67K shares out of 2.03Mn outstanding shares.
• During the 90-day period through February 15, 2026, Cellectar Biosciences experienced a 0.03% increased in insider ownership, with total insider shares growing from 32.66K to 32.67K.
• There were no significant insider purchasers for Cellectar Biosciences in the last 90 days.
• As of February 15, 2026, Director John Neis recorded the highest insider sale volume at Cellectar Biosciences, offloading 198 shares during the preceding 90-day window.